Ensuring Educational Grants are Free from Commercial Influence and Bias

View
Devel

... (Array, 116 elements)
- page-title (String, 71 characters ) Ensuring Educational Grants are Free from Comme...
 - Ensuring Educational Grants are Free from Commercial Influence and Bias
- page-title-raw (String, 71 characters ) Ensuring Educational Grants are Free from Comme...
 - Ensuring Educational Grants are Free from Commercial Influence and Bias
- user-name (String, 9 characters ) Anonymous
- user-id (Integer) 0
- user-mail (String, 0 characters )
- site-url (String, 26 characters ) https://cmepeerreview.com/
- site-name (String, 15 characters ) CME Peer Review
- site-slogan (String, 0 characters )
- site-mission (String, 0 characters )
- site-mail (String, 22 characters ) site@cmepeerreview.com
- site-date-small (String, 16 characters ) 2025-06-17 16:05
- site-date-yyyy (String, 4 characters ) 2025
- site-date-yy (String, 2 characters ) 25
- site-date-month (String, 4 characters ) June
- site-date-mon (String, 3 characters ) Jun
- site-date-mm (String, 2 characters ) 06
- site-date-m (String, 1 characters ) 6
- site-date-ww (String, 2 characters ) 25
- site-date-date (String, 1 characters ) 2
- site-date-day (String, 7 characters ) Tuesday
- site-date-ddd (String, 3 characters ) Tue
- site-date-dd (String, 2 characters ) 17
- site-date-d (String, 2 characters ) 17
- site-date-raw (Integer) 1750194302
- site-date-since (String, 5 characters ) 0 sec
- current-page-title (String, 71 characters ) Ensuring Educational Grants are Free from Comme...
 - Ensuring Educational Grants are Free from Commercial Influence and Bias
- current-page-path-raw (String, 57 characters ) content/verifyce-large-pharmaceutical-company/d...
 - content/verifyce-large-pharmaceutical-company/devel/token
- current-page-path (String, 57 characters ) content/verifyce-large-pharmaceutical-company/d...
 - content/verifyce-large-pharmaceutical-company/devel/token
- current-page-url (String, 83 characters ) https://cmepeerreview.com/content/verifyce-larg...
 - https://cmepeerreview.com/content/verifyce-large-pharmaceutical-company/devel/token
- current-page-number (Integer) 1
- site-date (String, 16 characters ) 2025-06-17 16:05
- page-number (Integer) 1
- menu (String, 0 characters )
- menu-raw (String, 0 characters )
- menupath (String, 0 characters )
- menupath-raw (String, 0 characters )
- menu-link-title (String, 0 characters )
- menu-link-title-raw (String, 0 characters )
- menu-link-mlid (String, 0 characters )
- menu-link-plid (String, 0 characters )
- menu-link-parent-path (String, 0 characters )
- menu-link-parent-path-raw (String, 0 characters )
- nid (String, 2 characters ) 41
- type (String, 12 characters ) case_studies
- type-name (String, 10 characters ) Case Study
- language (String, 2 characters ) en
- title (String, 71 characters ) Ensuring Educational Grants are Free from Comme...
 - Ensuring Educational Grants are Free from Commercial Influence and Bias
- title-raw (String, 71 characters ) Ensuring Educational Grants are Free from Comme...
 - Ensuring Educational Grants are Free from Commercial Influence and Bias
- node-path-raw (String, 45 characters ) content/verifyce-large-pharmaceutical-company
- node-path (String, 45 characters ) content/verifyce-large-pharmaceutical-company
- node-url (String, 71 characters ) https://cmepeerreview.com/content/verifyce-larg...
 - https://cmepeerreview.com/content/verifyce-large-pharmaceutical-company
- author-uid (String, 1 characters ) 1
- author-name (String, 7 characters ) pharmon
- author-name-raw (String, 7 characters ) pharmon
- author-mail (String, 24 characters ) phil_harmon@xelltech.com
- author-mail-raw (String, 24 characters ) phil_harmon@xelltech.com
- log-raw (String, 0 characters )
- log (String, 0 characters )
- node_comment_count (String, 1 characters ) 0
- unread_comment_count (Integer) 0
- small (String, 16 characters ) 2011-07-01 07:04
- yyyy (String, 4 characters ) 2011
- yy (String, 2 characters ) 11
- month (String, 4 characters ) July
- mon (String, 3 characters ) Jul
- mm (String, 2 characters ) 07
- m (String, 1 characters ) 7
- ww (String, 2 characters ) 26
- date (String, 1 characters ) 5
- day (String, 6 characters ) Friday
- ddd (String, 3 characters ) Fri
- dd (String, 2 characters ) 01
- d (String, 1 characters ) 1
- raw (String, 10 characters ) 1309521869
- since (String, 17 characters ) 13 years 50 weeks
- mod-small (String, 16 characters ) 2011-12-06 03:17
- mod-yyyy (String, 4 characters ) 2011
- mod-yy (String, 2 characters ) 11
- mod-month (String, 8 characters ) December
- mod-mon (String, 3 characters ) Dec
- mod-mm (String, 2 characters ) 12
- mod-m (String, 2 characters ) 12
- mod-ww (String, 2 characters ) 49
- mod-date (String, 1 characters ) 2
- mod-day (String, 7 characters ) Tuesday
- mod-ddd (String, 3 characters ) Tue
- mod-dd (String, 2 characters ) 06
- mod-d (String, 1 characters ) 6
- mod-raw (String, 10 characters ) 1323159456
- mod-since (String, 17 characters ) 13 years 28 weeks
- term (String, 23 characters ) ValidateCE - Supporters
- term-raw (String, 23 characters ) ValidateCE - Supporters
- term-id (String, 4 characters ) 2595
- vocab (String, 8 characters ) Products
- vocab-raw (String, 8 characters ) Products
- vocab-id (String, 2 characters ) 37
- field_client_name-raw (String, 28 characters ) Large Pharmaceutical Company
- field_client_name-formatted (String, 28 characters ) Large Pharmaceutical Company
- field_product-raw (String, 8 characters ) VerifyCE
- field_product-formatted (String, 8 characters ) VerifyCE
- field_key-raw (NULL)
- field_key-formatted (String, 0 characters )
- field_challenge-raw (String, 405 characters ) The client needed objective data to demonstr...
 - The client needed objective data to demonstrate to senior leadership that the policies and procedures for determining grant funding did not introduce any commercial bias or influence into those programs and activities.  Furthermore, they needed to demonstrate that the resulting activities were also free of commercial bias.  Key: Identification of Bias 
- field_challenge-formatted (String, 407 characters ) The client needed objective data to demonstr...
 - The client needed objective data to demonstrate to senior leadership that the policies and procedures for determining grant funding did not introduce any commercial bias or influence into those programs and activities.  Furthermore, they needed to demonstrate that the resulting activities were also free of commercial bias.   Key: Identification of Bias 
- field_chosen-raw (String, 349 characters ) The senior director of the IME department ch...
 - The senior director of the IME department chose CME Peer Review because of their independence from commercial interests, their experience and expertise in reviewing grant policies and procedures, and their national network of medical professionals who are rigorously trained as monitors and auditors for CME activities. 
- field_chosen-formatted (String, 350 characters ) The senior director of the IME department ch...
 - The senior director of the IME department chose CME Peer Review because of their independence from commercial interests, their experience and expertise in reviewing grant policies and procedures, and their national network of medical professionals who are rigorously trained as monitors and auditors for CME activities. 
- field_approach-raw (String, 466 characters ) The client requested that CME Peer R...
 - The client requested that CME Peer Review begin the process by conducting an initial “Pilot” program that would include reviewing the existing policies and procedures for determining grant funding and monitoring a representative group of CME activities (both live and enduring).  All activities chosen for review were conducted and released within a single quarter to establish an initial baseline of data.  
- field_approach-formatted (String, 468 characters ) The client requested that CME Peer R...
 - The client requested that CME Peer Review begin the process by conducting an initial “Pilot” program that would include reviewing the existing policies and procedures for determining grant funding and monitoring a representative group of CME activities (both live and enduring).  All activities chosen for review were conducted and released within a single quarter to establish an initial baseline of data.   
- field_solution-raw (String, 348 characters ) It was confirmed that the grant policies and...
 - It was confirmed that the grant policies and procedures process, as well, as the resulting activities were truly independent and free of commercial bias.  These findings were presented to senior leadership, including the US President, VP Medical Affairs, the Chief Compliance Officer, and the IME and compliance departments.  
- field_solution-formatted (String, 349 characters ) It was confirmed that the grant policies and...
 - It was confirmed that the grant policies and procedures process, as well, as the resulting activities were truly independent and free of commercial bias.  These findings were presented to senior leadership, including the US President, VP Medical Affairs, the Chief Compliance Officer, and the IME and compliance departments.  
- field_outcome-raw (String, 763 characters ) The senior leadership, compliance and IME de...
 - The senior leadership, compliance and IME departments were very satisfied with the process and results of this initial pilot project.  The IME department used the aggregate data as a value statement to petition for additional CME grant funding.   In addition, the compliance department generated a multi-year contract to CME Peer Review to monitor grant funded activities on a regular basis.  The IME department established certain parameters, such as types of activities, therapeutic categories, number of audits per year, etc. The results of the audits are collected and reported on a scheduled basis.  This validated the CME grant funding process and enabled the procurement of additional CME grant funds. 
- field_outcome-formatted (String, 764 characters ) The senior leadership, compliance and IME de...
 - The senior leadership, compliance and IME departments were very satisfied with the process and results of this initial pilot project.  The IME department used the aggregate data as a value statement to petition for additional CME grant funding.   In addition, the compliance department generated a multi-year contract to CME Peer Review to monitor grant funded activities on a regular basis.  The IME department established certain parameters, such as types of activities, therapeutic categories, number of audits per year, etc. The results of the audits are collected and reported on a scheduled basis.  This validated the CME grant funding process and enabled the procurement of additional CME grant funds. 
- termpath (String, 34 characters ) Supporters/ValidateCE - Supporters
- termpath-raw (String, 34 characters ) Supporters/ValidateCE - Supporters
- termalias (String, 50 characters ) category/products/supporters/validatece-supporters
- termalias-raw (String, 50 characters ) category/products/supporters/validatece-supporters
Krumo version 0.2a
| http://krumo.sourceforge.net
Called from /var/www/html/cmepeerreview.com/sites/all/modules/token/token.pages.inc, line 157

VerifyCE ValidateCE ValidateIE CEPilotTest

CME Peer Review offers external, 3rd party evaluation. The Company and its Founder are free of conflict of interest. Reviewers and Auditors are vetted for conflicts with manufacturers of products discussed in the content prior to being confirmed for each assignment; those with identified conflicts are not eligible for the proposed assignment.

Our team and advisors have devoted their professional careers to the field of accreditation, compliance, independent validation and healthcare delivery. Our intent is to enhance the quality and integrity of continuing education activities. The feedback we provide is based solely on merit of the education and is referenced to industry standards and regulatory requirements.

CME Peer Review

Primary links

Ensuring Educational Grants are Free from Commercial Influence and Bias

Krumo version 0.2a

Company

Solutions

Reviewers

Clients

News & Resources

Contact Us